A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution

PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

December 31, 2002

Conditions
Colonoscopy
Interventions
DRUG

Macrogol3350 NA sulphate NACl KCl ascorbic acid NA ascorbate

"1 pack will consist of 2L NRL 994 - 4 (2 x PEG + E/P + 2 x Vitamin C/C) sachets for the 2L of 2 sachets (1 x P plus 1 x C) will be dissolved in 1L of water. Each litre will be drunk within 1 hour followed by at least 500ml of any additional clear fluid."

DRUG

Macrogol3350 Na sulphate Na bicarbonate NaCl KCl

"1 pack will consist of 4L PEG + E - contains 4 sachets for the 4L of PEG + E/P/E. Each sachet will be dissolved in 1L of water. Each litre will be drunk within 1 hour."

Trial Locations (12)

22297

Abteilung für Innere Medizin, Israelitisches Krankenhaus, Hamburg

45239

Zentrum für Innere Medizin,, Essen

60318

Bürgerhospital Frankfurt e.V., Abteilung für interventionelle Endoskopie, Frankfurt am Main

63739

Chefarzt Innere Medizin, Klinikum Aschaffenburg, Aschaffenburg

65199

Dr.-Horst-Schmidt-Kliniken GmbH, Innere Medizin II, Wiesbaden

65929

Städtische Kliniken Frankfurt-Höchst, Frankfurt am Main

90766

Klinikum Fürth, Med. Klinik II, Fürth

91054

Waldkrankenhaus St. Marien,, Erlangen

92224

Chefarzt der Abt. Gastroenterologie, Klinikum St. Marien, Amberg

99097

Chefarzt, Katholisches Krankenhaus St. Johann Nepomuk, Erfurt

Unknown

Klinikum Dachau, Innere Medizin - Gastroenterologie, Dachau

D-95643

Kreiskrankenhaus, Tirschenreuth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Norgine

INDUSTRY